Much of the research into α-synuclein, the major component of Lewy bodies in Parkinson’s and other neurodegenerative diseases, focuses on its role in synaptic vesicles and membranes. But could other ...
A graduate student from the Massachusetts Institute of Technology (MIT) is poised to commercialize a new technology for improving the cost-effectiveness of mRNA manufacture. Nathan Stover is working ...
Creative Biolabs optimizes the mRNA drug development model by integrating sequence design, RNA-protein interaction ...
As the COVID-19 pandemic began to wreak havoc on the world in 2020, the biopharmaceutical industry started working tirelessly to develop a vaccine to stop this global threat. Emerging from this effort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback